Titel

Merkliste
1 Ergebnisse

The ECHELON-2 Trial: 5-year results of a randomized, phase ..:

Horwitz, S ; O'Connor, O. A ; Pro, B...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.annonc.2021.12.002. , 2021

Link: https://hal.univ-lille.fr/hal-04247540

RT Journal
T1 <Title>The ECHELON-2 Trial: 5-year results of a randomized, phase 3 study of brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftunivlille:oai:HAL:hal-04247540v1&Exemplar=1&LAN=DE
				
A1 Horwitz, S
A1 O'Connor, O. A
A1 Pro, B
A1 Trümper, L
A1 Iyer, S
A1 Advani, R
A1 Bartlett, N. L
A1 Christensen, J. H
A1 Morschhauser, Franck
A1 Domingo-Domenech, E
A1 Rossi, G
A1 Kim, W. S
A1 Feldman, T
A1 Menne, T
A1 Belada, D
A1 Illés, Á
A1 Tobinai, K
A1 Tsukasaki, K
A1 Yeh, S. P
A1 Shustov, A
A1 Hüttmann, A
A1 Savage, K. J
A1 Yuen, S
A1 Zinzani, P. L
A1 Miao, H
A1 Bunn, V
A1 Fenton, K
A1 Fanale, M
A1 Puhlmann, M
A1 Illidge, T
PB HAL CCSD; Elsevier
YR 2021
K1 brentuximab vedotin
K1 CHOP
K1 frontline treatment
K1 peripheral T-cell lymphoma
K1 randomized clinical trial
K1 overall survival
K1 [SDV]Life Sciences [q-bio]
JF info:eu-repo/semantics/altIdentifier/doi/10.1016/j.annonc.2021.12.002
LK http://dx.doi.org/https://hal.univ-lille.fr/hal-04247540
DO https://hal.univ-lille.fr/hal-04247540
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)